CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- 4 Open-market sale Director sold 2,406 shares at $123.65 ($297,502)
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale CLO & Secretary sold 2,000 shares at $99.60 ($199,201)
- 4 Open-market sale Chief Financial Officer sold 1,275 shares at an average $103.94 ($132,518)
- 4 Open-market sale President & COO sold 16,047 shares at an average $102.35 ($1,642,359)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Option exercise Chief Financial Officer acquired 1,486 shares (option exercise)
- 4 Option exercise President & COO acquired 5,774 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 753 shares (option exercise)
- 4 Open-market sale CLO & Secretary sold 1,500 shares at $106.39 ($159,591)
- 144 Insider Sale of Securities
Page 11 of 115 · 2,300 filings